Vetoquinol SA (LON:0O1O)

London flag London · Delayed Price · Currency is GBP · Price in EUR
73.50
-0.10 (-0.14%)
At close: May 9, 2025
-25.53%
Market Cap 729.71M
Revenue (ttm) 445.90M
Net Income (ttm) 48.53M
Shares Out n/a
EPS (ttm) 4.11
PE Ratio 15.04
Forward PE 14.34
Dividend 0.72 (0.98%)
Ex-Dividend Date Jun 4, 2025
Volume 1
Average Volume 10
Open 73.40
Previous Close 73.60
Day's Range 73.40 - 73.50
52-Week Range 76.60 - 108.99
Beta 0.78
RSI 37.75
Earnings Date Apr 24, 2025

About Vetoquinol

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1933
Employees 2,440
Stock Exchange London Stock Exchange
Ticker Symbol 0O1O
Full Company Profile

Financial Performance

In 2024, Vetoquinol's revenue was 539.20 million, an increase of 1.88% compared to the previous year's 529.27 million. Earnings were 58.69 million, an increase of 5.62%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.